“If we invest billions in university research, then this remains an abortive effort if we do not make sure at the same time that these…
Jérémie Meyer15.03.2017
The Basel-based venture capital firm BioMedPartners has raised CHF 75 million in the first closing of their fund BioMedInvest III, a healthcare venture capital fund…
Jérémie Meyer17.02.2017
The risk adjusted, net present value (rNPV) method is the standard valuation method used within pharma and biotech companies when valuing assets beyond discovery stage.…
Jérémie Meyer15.02.2017
The latest round in the title patent fight between The Broad and UC Berkelely over CRISPR/Cas9 tech goes to … Editas Medicine. The US Patent…
Jérémie Meyer15.02.2017
The two Basel-based companies Novartis and Roche invest more in research and development than all other international pharmaceutical companies, according to the 2016 EU Industrial…
Jérémie Meyer15.02.2017
Evolva, which manufactures ingredients for health, wellness and nutrition, has launched Veri-te, the brand for high-purity, sustainably produced resveratrol. The ingredient has been shown to…
Jérémie Meyer14.02.2017
The technology transfer organisation of the universities of Basel, Bern and Zurich helped more than 1,2000 new research collaborations in 2016. The funds resulting from…
Jérémie Meyer10.02.2017
‘Uberfication’ will change marketing and sales in the pharmaceutical sector, says Patrik Frei. This is already seen at healthcare companies, where digitalisation is making inroads.…
Jérémie Meyer09.02.2017
The pharmaceutical company Polyphor has received CHF 2.3 million to advance research work on a particular antibiotic. Polyphor has been very successful in developing medicines…
Jérémie Meyer09.02.2017
